Matthew W. Foehr, President and COO at LIGAND PHARMACEUTICALS INC (LGND), sold 89,094 shares at $176.86 ($15.8M) on 2021-02-04, disclosed to the SEC on 2021-02-05.
Seasonal sale ($15.8M) by President and COO — this insider has traded LGND in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $176.86 | 44,547 | $7.9M | 50.0% |
| 2 | $176.86 | 44,547 | $7.9M | 50.0% |
| Total | $176.86 avg | 89,094 | $15.8M | 100% |
| Filing → |
| OABI | SELL | 2026-02-17 | $35K | — | Filing → |
| VKTX | SELL | 2026-01-05 | $1.1M | — | Filing → |
| OABI | SELL | 2025-12-09 | $27K | — | Filing → |